Biopeak, a health-tech startup, just got $2.7 million in a new funding round led by NKSquared, which is Zerodha co-founder Nikhil Kamath’s investment thing. They want to create India’s best healthspan-focused care platform, so this money should help. Kamath already invested $1.43 million in them back in August 2024, so he must really believe in their data-driven healthcare idea that puts longevity first.
This new round brings Biopeak’s total funding up and strengthens its spot in India’s fast-growing health and wellness scene. The money will go toward growing the business, opening a new clinic, and making their diagnostic stuff, AI tools, research, and clinical programs way better. More and more people want health help that’s customized and focused on the long term, so Biopeak is trying to be the place that combines great testing, AI, and expert doctors.
Rishi Pardal and Shiva Subramanian started Biopeak in 2025. They run a different kind of health-tech and direct-to-consumer care thing, focusing on making people healthier longer instead of just treating them when they’re sick. They act like a family health office, giving people custom health plans that help them get their metabolism, body strength, and lifespan in good shape over time. This shows that things are changing in India’s healthcare world, with people caring more about staying healthy, performing well, and living a long life.
Biopeak’s platform uses all sorts of advanced tests, like organic acid profiling, microbiome mapping, whole-exome functional genomics, and salivary cortisol rhythm analysis. They also use cool imaging tech like MRI, CT scans, DXA, and ECHO to really understand a person’s health. Then, their clinics turn that info into plans that cover stuff like food, sleep, stress, hormones, and metabolism.
Biopeak is based in Bengaluru and mostly works with successful people, executives, and women who want science-based ways to stay healthy and live longer. Their programs mix advanced testing, doctor advice, wearable data, and AI insights made for Indian bodies, lifestyles, and disease risks. This focus on India is what makes them different from other wellness companies that don’t really get the Indian population.
Biopeak says they’ve grown steadily with more clients and services because people are learning about healthspan and preventive care. They started their first clinic in Bengaluru last year and are planning a second one soon as part of their growth plan. The new clinic should help them see more patients and do more research to make their programs even better.
This new investment also shows that investors are liking health-tech startups that combine tech, good doctors, and direct-to-consumer service. As India’s D2C health and wellness market becomes more mature, Biopeak is becoming a long-term player by focusing on results, keeping customers, and giving personalized care instead of just quick services.
With this new money, support from a well-known investor, and a solid plan to grow, Biopeak is ready to take things to the next level. They want to open more clinics, improve their AI testing, and build lasting relationships with people who want to take charge of their health with custom healthcare plans in India.
